An antidepressant class whose principal initial pharmacological action inhibits serotonin transport back into presynaptic cells. Initial transporter inhibition and subsequent clinical improvement need not have the same time course.
A selective serotonin reuptake inhibitor studied in several mental disorders. A favorable treatment response does not by itself establish that a simple serotonin deficiency caused the condition.[ref]
A randomized controlled trial of medication and cognitive-behavioral therapy for hypochondriasis by Brian A. Fallon and others. 2017; randomized pharmacotherapy comparison and qualified efficacy outcomes
Articles by others on the same topic
There are currently no matching articles.